다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
Bausch plus Lomb Corporation (BLCO)
Bausch plus Lomb Corporation (BLCO) 뉴스

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:BLCO

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/22	21:00	Business Wire	Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19	NYSE:BLCO	Bausch plus Lomb Corporation
2025/01/13	21:00	Business Wire	Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences	NYSE:BLCO	Bausch plus Lomb Corporation
2025/01/13	20:00	Business Wire	Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union	NYSE:BLCO	Bausch plus Lomb Corporation
2025/01/07	21:00	Business Wire	Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge	NYSE:BLCO	Bausch plus Lomb Corporation
2025/01/02	21:00	Business Wire	Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference	NYSE:BLCO	Bausch plus Lomb Corporation
2024/12/27	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/12/27	06:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/12/27	06:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/12/12	21:00	Business Wire	Bausch + Lomb Responds to Rumors of a Potential Sale	NYSE:BLCO	Bausch plus Lomb Corporation
2024/12/11	20:59	Business Wire	Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/11/14	21:00	Business Wire	Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs	NYSE:BLCO	Bausch plus Lomb Corporation
2024/11/02	05:27	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BLCO	Bausch plus Lomb Corporation
2024/10/31	05:32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:BLCO	Bausch plus Lomb Corporation
2024/10/30	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BLCO	Bausch plus Lomb Corporation
2024/10/30	20:00	Business Wire	Bausch + Lomb Announces Third-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation
2024/10/14	20:00	Business Wire	Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens	NYSE:BLCO	Bausch plus Lomb Corporation
2024/10/09	21:00	Business Wire	Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30	NYSE:BLCO	Bausch plus Lomb Corporation
2024/10/01	20:00	Business Wire	Bausch + Lomb Launches Opal™ Digital Marketplace in the United States	NYSE:BLCO	Bausch plus Lomb Corporation
2024/09/17	19:42	IH Market News	Investors Anticipate Retail Sales Data and Fed Decision; Oil Prices Dip as Investors Weigh U.S. Production	NYSE:BLCO	Bausch plus Lomb Corporation
2024/08/07	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/08/02	05:48	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:BLCO	Bausch plus Lomb Corporation
2024/08/02	05:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:BLCO	Bausch plus Lomb Corporation
2024/07/31	20:06	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BLCO	Bausch plus Lomb Corporation
2024/07/31	20:00	Business Wire	Bausch + Lomb Announces Second-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation
2024/07/30	08:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/07/30	08:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/07/30	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
2024/07/12	01:05	Business Wire	Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31	NYSE:BLCO	Bausch plus Lomb Corporation
2024/07/08	20:00	Business Wire	Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief	NYSE:BLCO	Bausch plus Lomb Corporation
2024/06/19	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation

검색 관련기사 보기:NYSE:BLCO

1 2 3 4 5 6 7 8 9 다음 >>

Gold vs US Dollar

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관